TRV GP IV, LLC
- SEC CIK
- 0001688325
- Latest filing
- Aug 7, 2026
Holdings in Q3 2024
Holdings as of Sep 30, 2024, filed Nov 6, 2024. Long positions only; changes compare share counts with Q2 2024.
- Positions
- 3
- 0 vs. Q2 2024
- Portfolio value
- $162.1M
- −$40.1M (−19.8%) vs. Q2 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| TNGXTango Therapeutics, Inc. | COM | 16,859,075 | $129.8M | 80.1% | −2,342,400−12.2% | Reduced | History |
| PLRXPliant Therapeutics, Inc. | COM | 2,132,867 | $23.9M | 14.8% | 00.0% | Unchanged | History |
| FULCFulcrum Therapeutics, Inc. | COM | 2,343,154 | $8.37M | 5.2% | 00.0% | Unchanged | History |